Related Experiment Video
Updated: May 30, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Comparison of neuroprotective efficacy of competitive and non-competitive AMPA antagonists in vitro
1Department of Biochemistry, EGIS Biological Laboratories, EGIS Pharmaceuticals Ltd., P.O. Box 100, H-1475 Budapest 10, Hungary.
Abstract:
The neuroprotective efficacy of the most potent competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and three recently developed 2,3-benzodiazepine non-competitive AMPA antagonists (GYKI 52466, 53405 and 53655) was investigated in primary cultures of rat telencephalic neurons. NBQX protected cultured neurons against AMPA (20 μM for 21-23 h) induced toxicity with EC(50) of 0.5 μM. In the same test GYKI 52466, 53405 and 53655 had EC(50) values of 10.6, 9.3 and 5.1 μM, respectively. Thus we found the competitive antagonist NBQX to be ten times more effective neuroprotectant in vitro than the most potent non-competitive GYKI compound (GYKI 53655).
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Antiepileptic Drugs: Glutamate Antagonists

